MAYA GUMANOVSKY: Open Payments
NPI 1164763173 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 16 payments from 6 companies in 2025. Trend: 2023 $573 · 2024 $269 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $275 |
| Novo Nordisk Inc | 8 | $226 |
| Lilly USA, LLC | 3 | $76 |
| Astellas Pharma US Inc | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
Products named: Ozempic, FREESTYLE LIBRE 3, Saxenda, KISUNLA, Wegovy, MOUNJARO, Veozah, Repatha.
Industry payments across CA — which companies pay providers there.
